These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12572301)

  • 21. [Pharmacotherapy of borderline disorders. A review of the literature].
    Dulz B
    Nervenarzt; 1994 Nov; 65(11):755-61. PubMed ID: 7816151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Personality disorder].
    André C
    Rev Prat; 2008 Mar; 58(5):551-6; quiz 575. PubMed ID: 18524115
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacotherapy in personality disorders].
    Wedekind D; Bandelow B; Rüther E
    Fortschr Neurol Psychiatr; 2005 May; 73(5):259-67. PubMed ID: 15880304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
    Nosè M; Cipriani A; Biancosino B; Grassi L; Barbui C
    Int Clin Psychopharmacol; 2006 Nov; 21(6):345-53. PubMed ID: 17012981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic treatment in the borderline patient: advantages and techniques.
    Soloff PH
    J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination of dialectic and behavioral therapy (DBT) and duloxetin in kleptomania].
    Rudel A; Hubert C; Juckel G; Edel MA
    Psychiatr Prax; 2009 Sep; 36(6):293-6. PubMed ID: 18924062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychotropic drugs in primary care].
    Cuche H
    Bull Acad Natl Med; 1997; 181(6):1105-14. PubMed ID: 9453835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trials of treatment for personality disorders.
    Paris J
    Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders.
    Mackinnon DF; Pies R
    Bipolar Disord; 2006 Feb; 8(1):1-14. PubMed ID: 16411976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacotherapy of patients with the borderline personality disorders].
    Ogłodek E; Araszkiewicz A
    Pol Merkur Lekarski; 2011 Dec; 31(186):381-3. PubMed ID: 22239012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of change in borderline personality disorder.
    Goldberg SC
    Psychopharmacol Bull; 1989; 25(4):550-5. PubMed ID: 2576568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.
    Soloff PH
    Bull Menninger Clin; 1998; 62(2):195-214. PubMed ID: 9604516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association.
    American Psychiatric Association Practice Guidelines
    Am J Psychiatry; 2001 Oct; 158(10 Suppl):1-52. PubMed ID: 11665545
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
    Van den Eynde F; Senturk V; Naudts K; Vogels C; Bernagie K; Thas O; van Heeringen C; Audenaert K
    J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ["Stealing madness"--kleptomania].
    Polak DM; Dannon PN
    Harefuah; 2001 Jun; 140(6):473-5, 567. PubMed ID: 11420843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
    Mallinger JB; Lamberti SJ
    J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interface between borderline personality disorder and bipolar spectrum disorders.
    Paris J; Gunderson J; Weinberg I
    Compr Psychiatry; 2007; 48(2):145-54. PubMed ID: 17292705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder.
    Faltus FJ
    Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differential diagnosis of psychotic symptoms in adolescents and young adults with borderline personality disorder].
    Dammann G; Walter M
    Psychiatr Prax; 2003 Sep; 30(6):304-11. PubMed ID: 12970815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.